August 06, 2013
A New York federal judge on Monday refused to kill AstraZeneca's suit seeking nearly $500 million over Andrx Pharmaceuticals Inc.'s manufacture of a generic version of its indigestion drug Prilosec, saying the suit doesn't raise the possibility of an improper double recovery.